Trials / Completed
CompletedNCT00160498
Testing the Efficacy of Different Dosages of Lercanidipine to Reduce Hypertensive Blood Pressure in Normal Weight and Obese Patients
A Double-Blind, Randomized, Multicenter, Placebo-Controlled, Parallel, Dose-Titration Study to Assess the Efficacy of Lercanidipine 10 mg and 20 mg Once Daily p. o. in Hypertensive Subjects (I or II WHO) With Elevated Body Weight.
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 180 (planned)
- Sponsor
- UCB Pharma · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- —
Summary
A double blind study to examine the safety and efficacy of different dosages of lercanidipine in normal weight and obese patients with hypertension
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Lercanidipine |
Timeline
- Start date
- 2004-05-01
- Primary completion
- 2005-08-01
- Completion
- 2005-08-01
- First posted
- 2005-09-12
- Last updated
- 2008-03-10
Source: ClinicalTrials.gov record NCT00160498. Inclusion in this directory is not an endorsement.